Glucagon-like peptide-2 in umbilical cord blood from mature infants

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Glucagon-like peptide-2 in umbilical cord blood from mature infants. / Bodé, Susan; Hartmann, Bolette; Holst, Jens Juul; Greisen, Gorm.

In: Neonatology, Vol. 91, No. 1, 2007, p. 49-53.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Bodé, S, Hartmann, B, Holst, JJ & Greisen, G 2007, 'Glucagon-like peptide-2 in umbilical cord blood from mature infants', Neonatology, vol. 91, no. 1, pp. 49-53. https://doi.org/10.1159/000096971

APA

Bodé, S., Hartmann, B., Holst, J. J., & Greisen, G. (2007). Glucagon-like peptide-2 in umbilical cord blood from mature infants. Neonatology, 91(1), 49-53. https://doi.org/10.1159/000096971

Vancouver

Bodé S, Hartmann B, Holst JJ, Greisen G. Glucagon-like peptide-2 in umbilical cord blood from mature infants. Neonatology. 2007;91(1):49-53. https://doi.org/10.1159/000096971

Author

Bodé, Susan ; Hartmann, Bolette ; Holst, Jens Juul ; Greisen, Gorm. / Glucagon-like peptide-2 in umbilical cord blood from mature infants. In: Neonatology. 2007 ; Vol. 91, No. 1. pp. 49-53.

Bibtex

@article{2d4a64680dc34925a2b3678c12b841ca,
title = "Glucagon-like peptide-2 in umbilical cord blood from mature infants",
abstract = "BACKGROUND: Glucagon-like peptide-2 (GLP-2) seems to be a highly specific intestinotrophic mediator. From animal studies, GLP-2 is known to increase in the early neonatal period before it falls to adult level. No studies in newborn infants addressing this specific subject have been published so far.OBJECTIVES: To measure GLP-2 concentrations in umbilical cord blood from healthy mature infants and to assess any influence from the processes associated with spontaneous birth to GLP-2 production.SUBJECTS: Twenty-one children delivered by elective cesarean section for maternal reasons and 18 children delivered spontaneously vaginally and without complications were included. Gestational age (GA) was median (range) 38.7 (40.7-37.1) weeks and 40.2 (41.9-38) weeks, and birth weight was median (range) 3,210 (4,820-2,100) g and 3,396 (4,225-3,050) g, respectively. The infants had no diagnosed diseases or malformations.METHODS: Umbilical cord blood was collected shortly after birth. Plasma was separated and GLP-2 immunoreactivity was measured with a specific NH(2)-terminal radioimmunoassay.RESULTS: GLP-2 was detected in all samples. Mean values +/-SD were 16.7 +/- 3.9 pmol/l and range was 32-11 pmol/l, which is comparable to adult fasting levels. No significant correlation to birth weight (p = 0.087) or to cesarean section (p = 0.059) was found. In multiple linear regression analysis (GLP-2 vs. GA + cesarean section), neither vaginal delivery nor GA were statistically significantly related to the level of GLP-2 (p = 0.28 and 0.18), respectively.CONCLUSIONS: GLP-2 is present in human cord blood by the time of birth. The level of GLP-2 is comparable to adult fasting levels. Spontaneous birth at most induces a minor increase in GLP-2 in term infants. In the narrow age interval studied, no significant effect of maturation was seen.",
keywords = "Birth Weight, Delivery, Obstetric, Female, Fetal Blood, Gestational Age, Glucagon-Like Peptide 2, Humans, Infant, Newborn, Male, Regression Analysis",
author = "Susan Bod{\'e} and Bolette Hartmann and Holst, {Jens Juul} and Gorm Greisen",
year = "2007",
doi = "10.1159/000096971",
language = "English",
volume = "91",
pages = "49--53",
journal = "Neonatology",
issn = "1661-7800",
publisher = "S Karger AG",
number = "1",

}

RIS

TY - JOUR

T1 - Glucagon-like peptide-2 in umbilical cord blood from mature infants

AU - Bodé, Susan

AU - Hartmann, Bolette

AU - Holst, Jens Juul

AU - Greisen, Gorm

PY - 2007

Y1 - 2007

N2 - BACKGROUND: Glucagon-like peptide-2 (GLP-2) seems to be a highly specific intestinotrophic mediator. From animal studies, GLP-2 is known to increase in the early neonatal period before it falls to adult level. No studies in newborn infants addressing this specific subject have been published so far.OBJECTIVES: To measure GLP-2 concentrations in umbilical cord blood from healthy mature infants and to assess any influence from the processes associated with spontaneous birth to GLP-2 production.SUBJECTS: Twenty-one children delivered by elective cesarean section for maternal reasons and 18 children delivered spontaneously vaginally and without complications were included. Gestational age (GA) was median (range) 38.7 (40.7-37.1) weeks and 40.2 (41.9-38) weeks, and birth weight was median (range) 3,210 (4,820-2,100) g and 3,396 (4,225-3,050) g, respectively. The infants had no diagnosed diseases or malformations.METHODS: Umbilical cord blood was collected shortly after birth. Plasma was separated and GLP-2 immunoreactivity was measured with a specific NH(2)-terminal radioimmunoassay.RESULTS: GLP-2 was detected in all samples. Mean values +/-SD were 16.7 +/- 3.9 pmol/l and range was 32-11 pmol/l, which is comparable to adult fasting levels. No significant correlation to birth weight (p = 0.087) or to cesarean section (p = 0.059) was found. In multiple linear regression analysis (GLP-2 vs. GA + cesarean section), neither vaginal delivery nor GA were statistically significantly related to the level of GLP-2 (p = 0.28 and 0.18), respectively.CONCLUSIONS: GLP-2 is present in human cord blood by the time of birth. The level of GLP-2 is comparable to adult fasting levels. Spontaneous birth at most induces a minor increase in GLP-2 in term infants. In the narrow age interval studied, no significant effect of maturation was seen.

AB - BACKGROUND: Glucagon-like peptide-2 (GLP-2) seems to be a highly specific intestinotrophic mediator. From animal studies, GLP-2 is known to increase in the early neonatal period before it falls to adult level. No studies in newborn infants addressing this specific subject have been published so far.OBJECTIVES: To measure GLP-2 concentrations in umbilical cord blood from healthy mature infants and to assess any influence from the processes associated with spontaneous birth to GLP-2 production.SUBJECTS: Twenty-one children delivered by elective cesarean section for maternal reasons and 18 children delivered spontaneously vaginally and without complications were included. Gestational age (GA) was median (range) 38.7 (40.7-37.1) weeks and 40.2 (41.9-38) weeks, and birth weight was median (range) 3,210 (4,820-2,100) g and 3,396 (4,225-3,050) g, respectively. The infants had no diagnosed diseases or malformations.METHODS: Umbilical cord blood was collected shortly after birth. Plasma was separated and GLP-2 immunoreactivity was measured with a specific NH(2)-terminal radioimmunoassay.RESULTS: GLP-2 was detected in all samples. Mean values +/-SD were 16.7 +/- 3.9 pmol/l and range was 32-11 pmol/l, which is comparable to adult fasting levels. No significant correlation to birth weight (p = 0.087) or to cesarean section (p = 0.059) was found. In multiple linear regression analysis (GLP-2 vs. GA + cesarean section), neither vaginal delivery nor GA were statistically significantly related to the level of GLP-2 (p = 0.28 and 0.18), respectively.CONCLUSIONS: GLP-2 is present in human cord blood by the time of birth. The level of GLP-2 is comparable to adult fasting levels. Spontaneous birth at most induces a minor increase in GLP-2 in term infants. In the narrow age interval studied, no significant effect of maturation was seen.

KW - Birth Weight

KW - Delivery, Obstetric

KW - Female

KW - Fetal Blood

KW - Gestational Age

KW - Glucagon-Like Peptide 2

KW - Humans

KW - Infant, Newborn

KW - Male

KW - Regression Analysis

U2 - 10.1159/000096971

DO - 10.1159/000096971

M3 - Journal article

C2 - 17344652

VL - 91

SP - 49

EP - 53

JO - Neonatology

JF - Neonatology

SN - 1661-7800

IS - 1

ER -

ID: 132050270